Tearful Jesy Nelson Gives ‘Bitter Sweet’ Response to SMA Screening Update
Jesy Nelson, the former Little Mix singer and devoted mother, has opened up emotionally about Scotland’s recent announcement to introduce newborn screening for Spinal Muscular Atrophy (SMA). This significant healthcare advancement marks Scotland as the first part of the UK to implement such testing, offering hope to families affected by this debilitating genetic condition. However, Jesy’s reaction is one of mixed emotions—joy for the progress made but sorrow that similar screening is not yet available in England, where her twin daughters continue to live with SMA.
Jesy Nelson’s Emotional Reaction to SMA Newborn Screening in Scotland
On March 23, 2026, NHS Scotland officially added SMA to its newborn screening program, a move welcomed by medical professionals, charities, and families alike. Jesy Nelson, who has been candid about her daughters’ diagnosis with SMA, described the news as “bitter sweet.” Her twin daughters, Ocean and Story, were born in May 2025 and diagnosed with the most severe and common form of SMA in January 2026. This neuromuscular disease progressively weakens muscles by affecting motor nerve cells in the spinal cord, often leading to a significantly shortened life expectancy without early intervention.
Jesy took to Instagram to share her heartfelt thoughts: “Today my heart feels super heavy. It’s a very bitter sweet moment today knowing Scotland has become the first UK nation to screen babies for SMA. We’re so close, yet so far. I will never be able to understand why we are still not testing for it in England.”
Her words highlight the frustration many families face when life-saving medical advancements are not uniformly available across the UK. Jesy’s advocacy underscores the urgent need for England to follow Scotland’s lead and include SMA in its newborn screening tests.
What the SMA Screening Update Means for Families in Scotland
The introduction of SMA screening in Scotland is a landmark step forward. Supported by external funding, the Scottish Newborn Screening Laboratory in Glasgow has acquired specialist equipment to test every baby born in Scotland—approximately 45,000 annually. This universal screening will enable early diagnosis and timely treatment, often before symptoms even appear.
SMA UK, a leading charity supporting affected families, praised the initiative, stating: “This marks a hugely positive step forward for babies and families across Scotland and brings the country in line with many others around the world that already screen for SMA at birth.”
Early detection is crucial because disease-modifying treatments approved by NHS Scotland can dramatically improve outcomes. Babies diagnosed through screening have the potential to follow near-normal developmental pathways, significantly enhancing their quality of life and life expectancy.
Jesy Nelson’s Ongoing Advocacy and Personal Journey
Jesy Nelson has been transparent about her family’s journey with SMA, sharing updates on social media to raise awareness and support. Even before giving birth, Jesy allowed cameras to document her pregnancy, and despite the challenging diagnosis, she continues to film her daughters’ lives to shed light on SMA’s realities.
In a recent Q&A session, Jesy expressed her hope that people will continue to follow their story: “When the girls got their diagnosis, we decided that we wanted to continue filming. As hard as it was, we were like, ‘You know what? There’s a reason you guys are here, and we’ve got to make the best out of this situation.’”
Jesy’s primary mission remains clear: to push for SMA to be included in England’s newborn heel prick test. She said, “I’m sure you guys are aware, like, I’m trying to get it made part of the heel prick test. That’s my main goal right now, as well as looking after my beautiful girls.”
Her determination to create change is fueled by a belief that sharing her family’s experience can influence policy and save lives. Jesy’s story is a powerful reminder of the importance of early diagnosis and the impact of advocacy on healthcare advancements.
Why SMA Screening in Newborns Is a Vital Step Forward
Spinal Muscular Atrophy is a genetic disorder that affects motor neurons, leading to muscle wasting and weakness. Without early detection and treatment, children with SMA face severe health challenges and often have a limited life expectancy. The introduction of newborn screening programs for SMA allows for early intervention with treatments such as gene therapy and other disease-modifying drugs.
Countries that have implemented SMA screening at birth have seen remarkable improvements in patient outcomes. Early treatment can slow disease progression, improve motor function, and extend life expectancy, transforming what was once a fatal diagnosis into a manageable condition.
Scotland’s pioneering step sets a precedent for the rest of the UK and highlights the urgent need for England and other regions to adopt similar screening protocols. Jesy Nelson’s advocacy brings much-needed attention to this issue, emphasizing that no family should have to endure the uncertainty and heartbreak of late diagnosis.
The Role of Charities and Public Awareness
Organizations like SMA UK play a critical role in supporting families, funding research, and campaigning for policy changes. Public awareness campaigns, often amplified by high-profile advocates like Jesy Nelson, help to educate the public and policymakers about the importance of newborn screening for SMA.
By sharing personal stories and highlighting the benefits of early detection, these efforts contribute to a growing movement aimed at making SMA screening a standard part of newborn healthcare across the UK.
Conclusion
Jesy Nelson’s tearful yet resolute response to Scotland’s SMA screening update shines a spotlight on the critical need for early diagnosis of this life-altering condition. While the announcement brings hope to many families, it also underscores the disparities in healthcare access within the UK. Jesy’s ongoing advocacy is a powerful call to action for England to implement newborn SMA screening, ensuring that no child’s life is limited by delayed diagnosis.
If you want to support Jesy Nelson’s mission and help raise awareness about SMA, consider sharing this article and following SMA UK’s campaigns. Together, we can push for change and make newborn SMA screening a reality across the UK.
